01
Target and Chemistry
Share the target structure, relevant functional groups, solubility or stability limits, and any conjugation or presentation information already available.
Creative Biolabs Service
Selective Aptamer Screening for Structural Analogs
Creative Biolabs supports small-molecule aptamer selection when the main challenge is to distinguish one target from close structural analogs. We design the project around your target, analog panel, sample context, and selectivity goal. Counter-targets and background controls can be added when they help remove unwanted binders. Candidate review then considers both binding and cross-reactivity.
Our Structural-Analog Aptamer Screening Services
Service Scope and Project Fit
Our service is suited to small-molecule projects where closely related compounds may compete for aptamer recognition. Examples include metabolites, drug analogs, related contaminants, stereochemical variants, and members of the same chemical family.
We define the desired discrimination before selection starts. When close analogs should actively remove unwanted binders, Counter-SELEX may be included. If target immobilization could hide important chemical features, Capture-SELEX may be considered.
- Small-molecule targets with one or more close structural analogs or related compounds.
- Defined analog panels that reflect the selectivity question in the intended research use.
- Counter-target, matrix, linker, or support controls that help separate target binding from background binding.
Project Requirements
02
Structural-Analog Panel
List the closest analogs or counter-targets and explain which compounds must be rejected, tolerated, or compared.
03
Sample Context
Describe the intended matrix or research setting if it may affect binding, background, or cross-reactivity.
04
Selectivity Goal
Tell us the discrimination level that matters, the planned research use, and which cross-reactivity results would be most important to review.
You do not need to choose immobilization, partitioning, or counter-selection conditions before inquiry. Creative Biolabs can review the chemistry and analog panel and discuss a suitable selection design.
Deliverables
Candidate Information
- Candidate aptamer sequences identified from the selected pool, according to the agreed project scope.
- Candidate prioritization notes that consider target binding together with available selectivity data.
Selection and Evaluation Data
- Selection/enrichment observations generated within the agreed workflow.
- Target-versus-analog evaluation results when cross-reactivity testing is included in scope.
Project Summary
- A project summary describing the applied selection logic and the conditions relevant to interpretation.
- Recommendations for follow-up characterization when additional evidence is needed.
Final data outputs depend on target chemistry, analog availability, the sample context, and the agreed project plan.
Optional Services [When applicable]
Aptamer Specificity Analysis
Expand target-versus-analog testing and compare cross-reactivity across a broader panel.
Aptamer Binding Characterization
Measure binding under agreed conditions after candidates are selected.
Aptamer Optimization Services
Refine selected sequences or formats after useful selectivity has been demonstrated.
Aptamer Assay Development Services
Move suitable candidates into research-use assay development when that is part of the project goal.
Selection Strategy and Project Design
Target Chemistry, Presentation, and Immobilization Constraints
We assess whether the target-facing chemical features remain accessible and whether the same presentation logic can be applied to relevant controls. Linker or support interactions should not become easier to recognize than the small molecule itself. The presentation route is chosen to preserve the discrimination question, not simply to maximize immobilization.
Counter-Target and Cross-Reactivity Control Design
Counter-target challenge can be introduced in stages instead of at one fixed level. The closest analogs may receive stronger pressure after useful target-binding diversity has appeared. This helps distinguish target-preferring candidates from sequences that mainly recognize a shared chemical scaffold.
Partitioning and Selection Pressure for Molecular Discrimination
Selection pressure is increased step by step as the pool changes. We balance washing, partitioning, target level, and analog challenge so useful sequence diversity is not lost too early. The direction of enrichment is reviewed before stringency is increased again.
Our Structural-Analog Aptamer Screening Workflow
Target and Project Preparation
Confirm the target identity, project objective, relevant controls, material constraints, and the decision criteria that will be used to interpret candidate performance.
Library and Selection Setup
Establish the library/selection format and the positive, negative, or counter-selection conditions appropriate to the target and project design.
Iterative Selection and Enrichment
Cycle the selected pool through target exposure, partitioning, recovery, and amplification while adjusting pressure according to the agreed strategy.
Enrichment Monitoring and Optimization
Review enrichment behavior and, where needed, refine selection conditions or control pressure to reduce non-target/background enrichment.
Candidate Identification and Screening
Identify representative candidates from the enriched pool and screen them against the target under the defined evaluation conditions.
Candidate Evaluation and Project Deliverables
Compare candidate binding and specificity evidence available within scope, document key conditions, and prepare the agreed project handoff.
Why Choose SELEXTech
Selectivity-Focused Design
We start with the target and analogs that define the real selectivity challenge.
Chemistry-Aware Target Presentation
We consider how target chemistry and presentation may change which molecular features are available for binding.
Analog and Counter-Target Controls
We use related compounds and background controls when they help remove unwanted recognition.
Cross-Reactivity Evaluation
We review candidate binding together with analog cross-reactivity so affinity is not judged alone.
Research Applications
Aptamer Biosensing
Develop recognition elements for research biosensing where closely related compounds may interfere with the signal.
Environmental, Food & Agricultural Research
Support selectivity studies in environmental research, food safety research, and agricultural research.
Metabolic & Endocrine Research
Study hormones, metabolites, and related small molecules when analog discrimination is important.
Drug Discovery Research
Screen target compounds against close analogs, metabolites, or related chemical structures in research workflows.
Published Data
A 2025 study by Zhao and colleagues provides a useful literature example of the specificity problem posed by closely related small molecules.1 The authors developed steroid-targeting aptamers for hydrocortisone and testosterone and reported that several comparison steroids differed by only a few functional groups. Their workflow explicitly used counter-selection to address specificity limits that could arise from a shared steroid scaffold. In the reported binding data, selected aptamers showed at least a ten-fold affinity difference against other steroid targets, with discrimination patterns influenced by structural similarity. The study used a deep-learning-assisted SELEX framework. It illustrated that: a structural-analog project needs an intentional analog panel, selection pressure that challenges shared chemical features, and direct cross-reactivity testing before specificity claims are made.
Frequently Asked Questions
How should I choose the structural analogs for a selectivity panel?
Prioritize molecules that are closest in structure, most likely to coexist with the target, or most consequential if cross-reactivity occurs. It is helpful to distinguish strict counter-targets from secondary comparators before the project is scoped.
How much target material is required?
There is no universal amount for every small-molecule project. Material needs depend on the target presentation strategy, selection format, number of controls, and planned candidate evaluation. Share the available amount and format so feasibility can be reviewed.
Does the small molecule have to be immobilized?
Not always. Direct immobilization is one option, but it can mask functional groups or introduce support-binding artifacts. The appropriate format depends on available chemistry and the recognition feature that should remain accessible.
When is Counter-SELEX useful for structural analogs?
Counter-SELEX is particularly relevant when close analogs define the specificity boundary. It is most useful when the analogs can actively deplete sequences recognizing shared structural features without eliminating potentially useful target-preferring binders.
When should Capture-SELEX be considered instead?
Capture-SELEX may be considered when direct target immobilization is problematic or when a solution-phase target interaction is preferred. The fit depends on target chemistry, library format, and the partitioning mechanism required for the project.
How is cross-reactivity evaluated after selection?
Candidate evaluation should compare target binding with the agreed analog or control panel under clearly documented conditions. The exact assay and concentration design are project-specific and should be selected to match the intended research question.
References
- Zhao, Zibin, Haosi Lin, Hoi Ying Lau, Hao Chen, and I-Ming Hsing. “Structure-enhanced deep learning accelerates aptamer selection for small molecule families like steroids.” Briefings in Bioinformatics 26.6 (2025): bbaf680. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1093/bib/bbaf680
